Articles by Caroline A. Sabin

1 2 3 4 5

Abacavir use and risk of recurrent myocardial infarction

Sabin, Caroline A.; Ryom, Lene; d’Arminio Monforte, Antonella; More

AIDS. 32(1):79-88, January 2, 2018.

Improved kidney function in patients who switch their protease inhibitor from atazanavir or lopinavir to darunavir

Jose, Sophie; Nelson, Mark; Phillips, Andrew; More

AIDS. 31(4):485-492, February 20th, 2017.

Is nelfinavir exposure associated with cancer incidence in HIV-positive individuals?

Boettiger, David C.; Sabin, Caroline A.; Grulich, Andrew; More

AIDS. 30(10):1629-1637, June 19th, 2016.

Relative contribution of HIV infection, demographics and body mass index to bone mineral density

Cotter, Aoife G.; Sabin, Caroline A.; Simelane, Sibongile; More

AIDS. 28(14):2051-2060, September 10th, 2014.

Failure to achieve a CD4+ cell count response on combination antiretroviral therapy despite consistent viral load suppression

O’Connor, Jemma L.; Smith, Colette J.; Lampe, Fiona C.; More

AIDS. 28(6):919-924, March 27th, 2014.

Associations between immune depression and cardiovascular events in HIV infection

Sabin, Caroline A.; Ryom, Lene; De Wit, Stephane; More

AIDS. 27(17):2735-2748, November 13th, 2013.

Predicting risk of cancer during HIV infection: the role of inflammatory and coagulation biomarkers

Borges, Álvaro H.; Silverberg, Michael J.; Wentworth, Deborah; More

AIDS. 27(9):1433-1441, June 1st, 2013.

Atazanavir is not associated with an increased risk of cardio or cerebrovascular disease events

Monforte, Antonella d’Arminio; Reiss, Peter; Ryom, Lene; More

AIDS. 27(3):407-415, January 28th, 2013.

Predictors of pregnancy and changes in pregnancy incidence among HIV-positive women accessing HIV clinical care

Huntington, Susie E.; Thorne, Claire; Bansi, Loveleen K.; More

AIDS. 27(1):95-103, January 2nd, 2013.

Treatment switches during pregnancy among HIV-positive women on antiretroviral therapy at conception

Huntington, Susie E.; Bansi, Loveleen K.; Thorne, Claire; More

AIDS. 25(13):1647-1655, August 24th, 2011.

Reasons for modification and discontinuation of antiretrovirals: results from a single treatment centre

Mocroft, Amanda; Youle, Michael; Moore, Antonia; More

AIDS. 15(2):185-194, January 26th, 2001.

The virological response to highly active antiretroviral therapy over the first 24 weeks of therapy according to the pre-therapy viral load and the weeks 4–8 viral load

Lepri, Alessandro Cozzi; Miller, Veronica; Phillips, Andrew N.; More

AIDS. 15(1):47-54, January 5th, 2001.

The impact of protease inhibitor-containing highly active antiretroviral therapy on progression of HIV disease and its relationship to CD4 and viral load

Miller, Veronica; Sabin, Caroline A.; Phillips, Andrew N.; More

AIDS. 14(14):2129-2136, September 29th, 2000.

The changing pattern of admissions to a London hospital of patients with HIV: 1988-1997

Mocroft, Amanda; Barry, Simon; Sabin, Caroline A.; More

AIDS. 13(10):1255-1261, July 9th, 1999.

1 2 3 4 5